Kisqali (600 MG Dose) and Novoeight recombinant
Determining the interaction of Kisqali (600 MG Dose) and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali (600 MG Dose)-Novolin 70/30
- Kisqali (600 MG Dose)-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Kisqali (600 MG Dose)-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Kisqali (600 MG Dose)-Novolin N
- Kisqali (600 MG Dose)-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Kisqali (600 MG Dose)-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Kisqali Femara Co-Pack
- Novoeight recombinant-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Novoeight recombinant-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Novoeight recombinant-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Novoeight recombinant-Kitabis Pak
- Novoeight recombinant-Kitabis Pak inhalation